Implementation of a Nurse-Driven Intensive Insulin Infusion Protocol in a Surgical Intensive Care Unit
- All about insulin. // Diabetes Forecast;Aug94, Vol. 47 Issue 8, p57
Discusses various aspects of insulin. Source of insulin; Types of insulin; Details of insulin therapy for diabetics; Insulin delivery; Blood glucose control; Pointers on injecting insulin.
- Velosulin wins new approval. // Drug Topics;6/26/95, Vol. 139 Issue 12, p8
Reports that Velosulin BR has received approval for the use in continuous subcutaneous insulin infusion, a new indication. Novo Nordisk as drug manufacturer.
- Insulins. // Reactions Weekly;5/22/2010, Issue 1302, p29
The article describes the case of a 60-year-old woman, diagnosed with diabetes mellitus, who developed localised amyloid deposition at the site of repeated insulin injections and subsequent insulin resistance.
- No more needles? // Arthritis Today;Sep/Oct93, Vol. 7 Issue 5, p13
Cites the results of a research exploring the administration of insulin by oral inhalation. Comparison of insulin taken as aerosol and traditional injection in lowering blood glucose levels; Leading to alternative route of delivery for other peptide hormones; Caution that the study is only...
- Insulins. // Reactions Weekly;10/9/2010, Issue 1322, p18
The article describes the case of an 82-year-old man who presented with insulin antibodies leading to frequent episodes of hypoglycemia while receiving treatment with recombinant human insulins for type 2 diabetes mellitus, referencing a study published in the August 2010 issue of the journal...
- Possible Problem With Optipen Pro-1. Goksen, Damla; Darcan, Sukran; Buyukinan, Muammer; Kurt, Emine // Diabetes Care;Jul2006, Vol. 29 Issue 7, p1710
A letter to the editor concerning difficulties in the operation and use of the OptiPen Pro-1 insulin pen injection system is presented.
- Isoform-Specific Regulation of 5' AMP-Activated Protein Kinase in Skeletal Muscle From Obese Zucker (fa/fa) Rats in Response to Contraction. Barnes, Brian R.; Ryder, Jeffrey W.; Steiler, Tatiana L.; Fryer, Lee G.D.; Carling, David; Zierath, Juleen R. // Diabetes;Sep2002, Vol. 51 Issue 9, p2703
Glucose transport can be activated in skeletal muscle in response to insulin via activation of phosphoinositide (PI) 3-kinase and in response to contractions or hypoxia, presumably via activation of 5â€² AMP-activated protein kinase (AMPK). We determined the effects of insulin and muscle...
- Differential Interactions of Nateglinide and Repaglinide on the Human Î²-Cell Sulphonylurea Receptor 1. Hansen, Ann Maria K.; Christensen, Inge T.; Hansen, John Bondo; Carr, Richard D.; Ashcroft, Frances M.; Wahl, Philip // Diabetes;Sep2002, Vol. 51 Issue 9, p2789
Repaglinide and nateglinide represent a new class of insulin secretagogues, structurally unrelated to sulphonylureas, that were developed for the treatment of type 2 diabetes. The inhibitory effect of these drugs was investigated on recombinant wild-type and mutant Kir6.2/SUR1 channels expressed...
- Unnecessary insulin treatment for diabetics. Kromann, H.; Borch, E.; Gale, E.A.M. // British Medical Journal (Clinical Research Edition);11/21/1981, Vol. 283 Issue 6303, p1386
Investigates the unnecessary insulin treatment for diabetes. Indications for starting treatment with insulin; Classification of diabetes; Symptoms of hypogycemia.
- NICE takes right line on insulin. Kiln, Matthew // Pulse;6/8/2006, Vol. 66 Issue 23, p19
A letter to the editor is presented in response to Professor Kirby's letter in the May 18, 2006 issue regarding inhaled insulin.